Email this article Antibiotic treatment failure
- Authors: Alpatov S.P.1, Bogush N.V.1, Borozdenko D.A.1, Buyanova N.M.1, Ganshina I.V.1, Dibirova G.O.1, Dmitrieva N.B.1, Kalinina E.V.1, Kirillova A.V.1, Kiseleva N.M.1, Kukushkin G.V.1, Leonteva T.I.1, Maximov M.L.1, Markina E.V.1, Mileshina S.E.1, Tsitsuashvili M.D.1, Yurov D.E.1
-
Affiliations:
- N.I. Pirogov Russian National Research Medical University
- Issue: Vol 27, No 2 (2021)
- Pages: 175-182
- Section: Reviews
- URL: https://journals.rcsi.science/0869-2106/article/view/76378
- DOI: https://doi.org/10.17816/0869-2106-2021-27-2-175-182
- ID: 76378
Cite item
Open Access
Access granted
Subscription Access
Abstract
This review presents information on cases of antibiotic failure (insufficient effect) in the global population over the past three years. We analyzed scientific papers, clinical trial data, and the WHO Program for International Drug Monitoring (VigiBase) data from 2018 to 2020. The values of global success and safety rates of antibacterial drugs for medical use are presented. The findings may be of practical interest to physicians, researchers, developers, and healthcare regulators.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Sergey P. Alpatov
N.I. Pirogov Russian National Research Medical University
Email: immunosport@rambler.ru
ORCID iD: 0000-0003-2233-7301
MD, Cand. Sci. (Med.)
Russian Federation, 1 Ostrovityanova str., 117997, MoscowNadezhda V. Bogush
N.I. Pirogov Russian National Research Medical University
Email: nadinbogush@gmail.com
Russian Federation, 1 Ostrovityanova str., 117997, Moscow
Denis A. Borozdenko
N.I. Pirogov Russian National Research Medical University
Email: borozdenko@phystech.edu
ORCID iD: 0000-0002-6797-9722
Russian Federation, 1 Ostrovityanova str., 117997, Moscow
Natalia M. Buyanova
N.I. Pirogov Russian National Research Medical University
Email: natasha-buyanova@mail.ru
ORCID iD: 0000-0002-4073-475X
Russian Federation, 1 Ostrovityanova str., 117997, Moscow
Irina V. Ganshina
N.I. Pirogov Russian National Research Medical University
Email: july1119661@rambler.ru
ORCID iD: 0000-0003-4049-7907
Russian Federation, 1 Ostrovityanova str., 117997, Moscow
Gulnara O. Dibirova
N.I. Pirogov Russian National Research Medical University
Email: g.dibirova@mail.ru
ORCID iD: 0000-0002-1500-4974
MD, Cand. Sci. (Med.)
Russian Federation, 1 Ostrovityanova str., 117997, MoscowNatalia B. Dmitrieva
N.I. Pirogov Russian National Research Medical University
Email: natapharm@gmail.com
Scopus Author ID: 7101760859
MD, Cand. Sci. (Med.)
Russian Federation, 1 Ostrovityanova str., 117997, MoscowElena V. Kalinina
N.I. Pirogov Russian National Research Medical University
Email: lena_vk@mail.ru
Scopus Author ID: 8958305800
MD, Cand. Sci. (Med.)
Russian Federation, 1 Ostrovityanova str., 117997, MoscowAnna V. Kirillova
N.I. Pirogov Russian National Research Medical University
Email: kirillova6@yandex.ru
ORCID iD: 0000-0003-3966-4448
MD, Cand. Sci. (Med.)
Russian Federation, 1 Ostrovityanova str., 117997, MoscowNina M. Kiseleva
N.I. Pirogov Russian National Research Medical University
Author for correspondence.
Email: kiseleva.67@mail.ru
ORCID iD: 0000-0003-1754-9051
MD, Dr. Sci. (Biol.), Professor
Russian Federation, 1 Ostrovityanova str., 117997, MoscowGerman V. Kukushkin
N.I. Pirogov Russian National Research Medical University
Email: germanpharm@yandex.ru
ORCID iD: 0000-0002-1661-1071
MD, Cand. Sci. (Med.)
Russian Federation, 1 Ostrovityanova str., 117997, MoscowTatiana I. Leonteva
N.I. Pirogov Russian National Research Medical University
Email: leontevati@mail.ru
MD, Cand. Sci. (Biol.)
Russian Federation, 1 Ostrovityanova str., 117997, MoscowMaxim L. Maximov
N.I. Pirogov Russian National Research Medical University
Email: maksim_maksimov@mail.ru
ORCID iD: 0000-0002-8979-8084
MD, Dr. Sci. (Med.), Professor
Russian Federation, 1 Ostrovityanova str., 117997, MoscowElena V. Markina
N.I. Pirogov Russian National Research Medical University
Email: elvikmark2015@yandex.ru
ORCID iD: 0000-0002-5943-4423
Russian Federation, 1 Ostrovityanova str., 117997, Moscow
Svetlana E. Mileshina
N.I. Pirogov Russian National Research Medical University
Email: svetikshrv@rambler.ru
ORCID iD: 0000-0001-8082-9393
MD, Cand. Sci. (Med.)
Russian Federation, 1 Ostrovityanova str., 117997, MoscowMaia D. Tsitsuashvili
N.I. Pirogov Russian National Research Medical University
Email: mayan318@gmail.com
ORCID iD: 0000-0001-7761-8683
MD, Cand. Sci. (Biol.)
Russian Federation, 1 Ostrovityanova str., 117997, MoscowDmitry E. Yurov
N.I. Pirogov Russian National Research Medical University
Email: dmpharm@gmail.com
ORCID iD: 0000-0003-0178-8736
MD, Cand. Sci. (Med.)
Russian Federation, 1 Ostrovityanova str., 117997, MoscowReferences
- Evteev VA, Muslimova OV, Mazerkina IA, et al. Organic anion transporters and their influence on the toxicity of β-lactam antibiotics. Bezopasnost' i risk farmakoterapii. 2017;5(2):70–75. (In Russ).
- Molchan NV, Smirnova YA, Vel'ts NY, et al. Fluoroquinolone antibiotics: safety of use by the example of ciprofloxacin. Bezopasnost' i risk farmakoterapii. 2019;7(2):72–83. (In Russ). doi: 10.30895/2312-7821-2019-7-2-72-83
- Ortenberg EA, Khokhlyavina RM, Shpil'kina LV, Khokhlyavin RL. Local antibiotic resistance in a multidisciplinary state: is an annual assessment sufficient? Ural'skii meditsinskii zhurnal. 2007;(6):54–58. (In Russ).
- Ostroumova OD, Kochetkov AI, Pavleeva EE, Kravchenko EV. Drug-Induced Neutropenia and Agranulocytosis. Bezopasnost' i risk farmakoterapii. 2020;8(3):109–122. (In Russ). doi: 10.30895/2312-7821-2020-8-3-109-122
- Ostroumova OD, Shahova EY, Kochetkov AI. Drug-Induced Eosinophilia. Bezopasnost' i risk farmakoterapii. 2019;7(4):176–189. (In Russ). doi: 10.30895/2312-7821-2019-7-4-176-189
- Postnikov SS, Teplova NV, Nikolaev VV, et al. A Case of Multiple Antibiotic-Associated Hepatotoxicity in an Infant. Bezopasnost' i risk farmakoterapii. 2019;7(3):146–151. (In Russ). doi: 10.30895/2312-7821-2019-7-3-146-151
- Reshet'ko OV, Yakimova YN, Novokreshchenova IG. Antibacterials for systemic use as reflected in formularies at different levels. Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo. 2016;(3):62–66. (In Russ).
- Titova AR, Pasternak EY, Asetskaya L, et al. On the safety of antibacterial drugs used in pediatrics. Bezopasnost' i risk farmakoterapii. 2015;(2):12–22. (In Russ).
- Yakovlev S. Modern problems of antibiotic resistance in the hospital. Vrach. 2007;(1):9–12. (In Russ).
- elibrary [Internet]. Nauchnaya elektronnaya biblioteka [cited 25 Feb 2021]. Available from: https://elibrary.ru
- ncbi.nlm.nih.gov [Internet]. PubMed [cited 25 Feb 2021]. Available from: https://pubmed.ncbi.nlm.nih.gov
- Clinicaltrials [Internet]. Clinicaltrials [cited 25 feb 2021]. Available from: https://clinicaltrials.gov
- vigilyze [Internet]. Vigilyze [cited 25 Feb 2021]. Available from: https://vigilyze.who-umc.org
- Solodukhina OA, Verlan NV, Kochkina EO, Rozhkova NY. Monitoring of antibacterial drug safety in clinical practice. Izvestiya vuzov. Prikladnaya khimiya i biotekhnologiya. 2018;8(2):117–124. (In Russ). doi: 0.21285/2227-2925-2018-8-2-117-124
Supplementary files
